Patents by Inventor Cheol AHN

Cheol AHN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibacterial protein CDL200 having lytic activity against
    Patent number: 12503494
    Abstract: The present invention relates to an antibacterial protein CDL200 with an antibacterial activity specific against Clostridioides difficile. More specifically, the present invention relates to an antibacterial protein CDL200 specific to Clostridioides difficile that may infect and cause disease in animals including humans, the antibacterial protein CDL200 being characterized by having the ability to specifically lyse the Clostridioides difficile and containing the amino acid sequence represented by SEQ ID NO: 1. In addition, the present invention relates to a pharmaceutical composition for treating an infection or disease caused by Clostridioides difficile, the composition containing the antibacterial protein CDL200 specific to Clostridioides difficile as an active ingredient.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: December 23, 2025
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Cheol Ahn, Soo Youn Jun, Sang Hyeon Kang
  • ANTIBACTERIAL PROTEIN CDL200 HAVING LYTIC ACTIVITY AGAINST CLOSTRIDIOIDES DIFFICILE
    Publication number: 20230159599
    Abstract: The present invention relates to an antibacterial protein CDL200 with an antibacterial activity specific against Clostridioides difficile. More specifically, the present invention relates to an antibacterial protein CDL200 specific to Clostridioides difficile that may infect and cause disease in animals including humans, the antibacterial protein CDL200 being characterized by having the ability to specifically lyse the Clostridioides difficile and containing the amino acid sequence represented by SEQ ID NO: 1. In addition, the present invention relates to a pharmaceutical composition for treating an infection or disease caused by Clostridioides difficile, the composition containing the antibacterial protein CDL200 specific to Clostridioides difficile as an active ingredient.
    Type: Application
    Filed: March 31, 2021
    Publication date: May 25, 2023
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Cheol Ahn, Soo Youn Jun, Sang Hyeon Kang
  • Compositions and methods for inhibiting the proliferation of pathogenic
    Patent number: 11596659
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Myoviridae bacteriophage Esc-COP-18 having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Myoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Myoviridae bacteriophage.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: March 7, 2023
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Hyoung Rok Paik, Hyun Joo Im, Hyun Jin Yu, Cheol Ahn, Tae Yeol Kim, Soo Youn Jun, Sang Hyeon Kang
  • COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF PATHOGENIC ESCHERICHIA COLI
    Publication number: 20210353695
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Myoviridae bacteriophage (Esc-COP-18) having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Myoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Myoviridae bacteriophage.
    Type: Application
    Filed: May 12, 2020
    Publication date: November 18, 2021
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Hyun Joo IM, Hyun Jin YU, Cheol AHN, Tae Yeol KIM, Soo Youn JUN, Sang Hyeon KANG